NDC 76420-534 – BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC76420-534

Product details

Brand name
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
Generic name
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
Labeler
Asclemed USA, Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA209069
Marketed since
January 22, 2021
Listing expires
December 31, 2026
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE →

Package NDC codes (1)

Package NDCDescriptionSince
76420-534-3030 TABLET in 1 BOTTLE, PLASTIC (76420-534-30)Jan 27, 2023

Other BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE products